LPL Financial Portfolio holdings
LPL Financial, founded in 1989 through the merger of Linsco and Private Ledger and headquartered in San Diego, California, is the largest independent broker-dealer in the U.S., supporting over 22,000 financial advisors who manage more than $1.4 trillion in advisory and brokerage assets as of late 2024. Serving independent advisors, banks, and credit unions, LPL provides a robust technology platform, research, and back-office support, enabling advisors to offer personalized wealth management, retirement planning, and investment services to clients without proprietary products. The firm, publicly traded since 2010 under CEO Dan Arnold, has grown through acquisitions like Waddell & Reed’s wealth management business in 2021, emphasizing flexibility and advisor autonomy. With additional offices in Fort Mill, South Carolina, and Boston, LPL Financial remains a leader in empowering advisors amid a shifting financial landscape.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$97.5M |
| 2 |
Vanguard Total Stock Market ETF
VTI
|
$67.1M |
| 3 |
Health Care Select Sector SPDR Fund
XLV
|
$66.3M |
| 4 |
iShares Russell 2000 ETF
IWM
|
$56.3M |
| 5 |
Invesco QQQ Trust
QQQ
|
$52.4M |
Top Sells
| 1 |
Invesco BuyBack Achievers ETF
PKW
|
$117M |
| 2 |
SPDR Gold Trust
GLD
|
$51.3M |
| 3 |
SPDR S&P MidCap 400 ETF Trust
MDY
|
$40.8M |
| 4 |
SPDR S&P Homebuilders ETF
XHB
|
$35.4M |
| 5 |
iShares MSCI Canada ETF
EWC
|
$33.1M |
Sector Composition
| 1 | Financials | 3.29% |
| 2 | Technology | 3.19% |
| 3 | Healthcare | 3.03% |
| 4 | Industrials | 2.66% |
| 5 | Energy | 2.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
First Trust Consumer Staples AlphaDEX Fund
FXG
$287M
| $30.6M | 0.17% |
718,212
+236,983
| +49% | +$10.1M |
|
127
Lockheed Martin
LMT
$105B
| $30.4M | 0.17% |
157,665
-2,265
| -1% | -$436K |
|
128
Starbucks
SBUX
$99.1B
| $29.7M | 0.16% |
724,970
-19,326
| -3% | -$793K |
|
|
SRV
129
NXG Cushing Midstream Energy Fund
SRV
$188M
| $29.5M | 0.16% |
250,150
+102,989
| +70% | +$12.2M |
|
130
First Trust Value Line Dividend Fund
FVD
$9.13B
| $29.1M | 0.16% |
1,206,259
-16,428
| -1% | -$397K |
|
131
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.44B
| $28.9M | 0.16% |
287,033
-18,370
| -6% | -$1.85M |
|
132
iShares S&P Small-Cap 600 Growth ETF
IJT
$6.21B
| $28.9M | 0.16% |
472,246
-27,036
| -5% | -$1.65M |
|
133
iShares S&P Mid-Cap 400 Growth ETF
IJK
$9.06B
| $28.9M | 0.16% |
723,712
+8,688
| +1% | +$347K |
|
134
Visa
V
$681B
| $28.8M | 0.16% |
438,900
+20,976
| +5% | +$1.37M |
|
135
Merck
MRK
$210B
| $28.8M | 0.16% |
530,875
+33,477
| +7% | +$1.81M |
|
136
iShares International Select Dividend ETF
IDV
$5.72B
| $28.4M | 0.16% |
843,947
-190,028
| -18% | -$6.4M |
|
137
Consumer Discretionary Select Sector SPDR Fund
XLY
$23.4B
| $28.3M | 0.15% |
391,931
+118,783
| +43% | +$8.57M |
|
|
DD
138
DELISTED
Du Pont De Nemours E I
DD
| $27.8M | 0.15% |
396,298
-23,260
| -6% | -$1.63M |
|
139
DNP Select Income Fund
DNP
$3.67B
| $27.7M | 0.15% |
2,626,460
-1,098,146
| -29% | -$11.6M |
|
140
Vanguard Mid-Cap Value ETF
VOE
$18.7B
| $27.5M | 0.15% |
307,223
-17,714
| -5% | -$1.58M |
|
141
Invesco Dorsey Wright Momentum ETF
PDP
$1.27B
| $27.5M | 0.15% |
668,694
+3,560
| +0.5% | +$146K |
|
142
First Trust NYSE Arca Biotechnology Index Fund
FBT
$1.07B
| $26.7M | 0.15% |
261,973
+34,503
| +15% | +$3.52M |
|
143
iShares US Energy ETF
IYE
$1.18B
| $26.7M | 0.15% |
594,926
+215,278
| +57% | +$9.65M |
|
144
Meta Platforms (Facebook)
META
$1.88T
| $26.2M | 0.14% |
335,737
+30,776
| +10% | +$2.4M |
|
145
PIMCO 1-5 Year US TIPS Index Exchange-Traded Fund
STPZ
$438M
| $25.1M | 0.14% |
485,458
-63,053
| -11% | -$3.26M |
|
146
Vanguard Health Care ETF
VHT
$15.6B
| $25M | 0.14% |
199,250
+28,910
| +17% | +$3.63M |
|
147
iShares US Consumer Discretionary ETF
IYC
$1.73B
| $24.6M | 0.13% |
714,964
+399,452
| +127% | +$13.8M |
|
148
Philip Morris
PM
$255B
| $23.9M | 0.13% |
293,908
+6,809
| +2% | +$555K |
|
149
IBM
IBM
$228B
| $23.9M | 0.13% |
155,684
-7,136
| -4% | -$1.09M |
|
150
Invesco Pharmaceuticals ETF
PJP
$265M
| $23.7M | 0.13% |
356,741
+22,591
| +7% | +$1.5M |
|